Emodin suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose

Molecular and Cellular Endocrinology

Volumn 307, Issue 1-2, 2009, Pages 157-162

  Li, Xuejuan ^a,c   Liu, Weihua ^a   Wang, Qin ^b   Liu, Peiqing ^a   Deng, Yanhui ^a   Lan, Tian ^a   Zhang, Xiaoyan ^a   Qiu, Baoming ^c   Ning, Hairong ^a   Huang, Heqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SHENZHEN CHILDREN'S HOSPITAL   (China)

Author keywords

CTGF; Emodin; Mesangial cells; p38MAPK; PPAR

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EMODIN; FIBRONECTIN; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG MECHANISM; EXTRACELLULAR MATRIX; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; UPREGULATION;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; EMODIN; FIBRONECTINS; FIBROSIS; GLUCOSE; MESANGIAL CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PPAR GAMMA; RATS;

EID: 67349274964     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.03.006     Document Type: Article

References (51)

1. Adams M., Reginato M.J., Shao D., Lazar M.A., and Chatterjee V.K. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272 (1997) 5128-5132
2. Aouadi M., Laurent K., Le Prot M., Marchand-Brustel Y., Bine truy B., and Bost F. Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages. Diabetes 55 (2006) 281-289
3. Battistutta R., Sarno S., De Moliner E., Papinutto E., Zanotti G., and Pinna L.A. The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2. J. Biol. Chem. 275 (2000) 29618-29622
4. Baylis C., Atzpodien E.A., Freshour G., and Engels K. Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity. J. Pharmacol. Exp. Ther. 307 (2003) 854-860
5. Berger J., Leibowitz M.D., Doebber T.W., et al. Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects. J. Biol. Chem. 274 (1999) 6718-6725
6. Bowlus C.L., McQuillan J.J., and Dean D.C. Characterization of three different elements in the 5′-flanking region of the fibronectin gene which mediate a transcriptional response to cAMP. J. Biol. Chem. 266 (1991) 1122-1127
7. Chan T.C., Chang C.J., Koonchanok N.M., and Geahlen R.L. Selective inhibition of the growth of ras-transformed human bronchial epithelial cells by emodin, a protein-tyrosine kinase inhibitor. Biochem. Biophys. Res. Commun. 193 (1993) 1152-1158
8. Cosio F.G. Effects of high glucose concentrations on human mesangial cell proliferation. J. Am. Soc. Nephrol. 5 (1995) 1600-1609
9. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268 (1993) 14553-14556
10. Deak M., Clifton A.D., Lucocq L.M., and Alessi D.R. Mitogen-and stress-activated protein kinase-1(MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17 (1998) 4426-4441
11. Fujimura T., Sakuma H., Konishi S., et al. FK614, a novel peroxisome proliferator-activated receptor gamma modulator, induces differential transactivation through a unique ligand-specific interaction with transcriptional coactivators. J. Pharmacol. Sci. 99 (2005) 342-352
12. Gilbert R.E., and Cooper M.E. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?. Kidney Int. 56 (1999) 1627-1637
13. Guha M., Xu Z.G., Tung D., Lanting L., and Natarajan R. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J. 21 (2007) 3355-3368
14. Ha H., Kim M.S., Park J., Huh J.Y., Huh K.H., Ahn H.J., and Kim Y.S. Mycophenolic acid inhibits mesangial cell activation through p38 MAPK inhibition. Life Sci. 79 (2006) 1561-1567
15. Igarashi M., Wakasaki H., Takahara N., Ishii H., Jiang Z.Y., Yamauchi T., Kuboki K., Meier M., Rhodes C.J., and King G.L. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J. Clin. Invest. 103 (1999) 185-195
16. Kang M.J., Wu X., Ly H., Thai K., and Scholey J.W. Effect of glucose on stress-activated protein kinase activity in mesangial cells and diabetic glomeruli. Kidney Int. 55 (1999) 2203-2214
17. Kang S.W., Adler S.G., Lapage J., and Natarajan R. p38 MAPK and MAPK kinase 3/6 mRNA and activities are increased in early diabetic glomeruli. Kidney Int. 60 (2001) 543-552
18. King G.L., Kunisaki M., Nishio Y., Inoguchi T., Shiba T., and Xia P. Biochemical and molecular mechanisms in the development of diabetic vascular complications. Diabetes. 45 Suppl. 3 (1996) S105-108
19. Kreisberg J.I., Garoni J.A., Radnik R., and Ayo S.H. High glucose and TGF beta 1 stimulate fibronectin gene expression through a cAMP response element. Kidney Int. 46 (1994) 1019-1024
20. Kreisberg J.I., Radnik R.A., and Kreisberg S.H. Phosphorylation of cAMP responsive element binding protein after treatment of mesangial cells with high glucose plus TGF beta or PMA. Kidney Int. 50 (1996) 805-810
21. Kumar A., Dhawan S., and Aggarwal B.B. Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene 17 (1998) 913-918
22. Kuo Y.C., Meng H.C., and Tsai W.J. Regulation of cell proliferation, inflammatory cytokine production and calcium mobilization in primary human T lymphocytes by emodin from Polygonum hypoleucum Ohwi. Inflamm. Res. 50 (2001) 73-82
23. Kuo Y.C., Tsai W.J., Meng H.C., Chen W.P., Yang L.Y., and Lin C.Y. Immune reponses in human mesangial cells regulated by emodin from Polygonum hypoleucum Ohwi. Life Sci. 68 (2001) 1271-1286
24. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., and Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369 (1994) 156-160
25. Lee N.J., Choi J.H., Koo B.S., Ryu S.Y., Han Y.H., Lee S.I., and Lee D.U. Antimutagenicity and cytotoxicity of the constituents from the aerial parts of Rumex acetosa. Biol. Pharm. Bull. 28 (2005) 2158-2161
26. Li J., Liu N.F., and Wei Q. Effect of rosiglitazone on cardiac fibroblast proliferation, nitric oxide production and connective tissue growth factor expression induced by advanced glycation end-products. J. Int. Med. Res. 36 (2008) 329-335
27. Lin C.L., Wang F.S., Kuo Y.R., Huang Y.T., Huang H.C., Sun Y.C., and Kuo Y.H. Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuries. Kidney Int. 69 (2006) 1593-1600
28. Liu B.F., Miyata S., Hirota Y., Higo S., Miyazaki H., Fukunaga M., Hamada Y., Ueyama S., Muramoto O., Uriuhara A., and Kasuga M. Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells. Kidney Int. 63 (2003) 947-957
29. Liu Z.C., Chow K.M., and Chang T.M. Evaluation of two protocols of uremic rat model: partial nephrectomy and infarction. Ren. Fail. 25 (2003) 935-943
30. Ljubimov A.V., Caballero S., Aoki A.M., Pinna L.A., Grant M.B., and Castellon R. Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization. Invest. Ophthalmol. Vis. Sci. 45 (2004) 4583-4591
31. McLennan S.V., Fisher E.J., Yue D.K., and Turtle J.R. High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy. Diabetes 43 (1994) 1041-1045
32. Nahman Jr. N.S., Leonhart K.L., Cosio F.G., and Hebert C.L. Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int. 41 (1992) 396-402
33. Nakagami H., Morishita R., Yamamoto K., Yoshimura S.I., Taniyama Y., Aoki M., Matsubara H., Kim S., Kaneda Y., and Ogihara T. Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high d-glucose in human endothelial cells. Diabetes 50 (2001) 1472-1481
34. Natarajan R., Scott S., Bai W., Yerneni K.K., and Nadler J. Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions. Hypertension 33 (1999) 378-384
35. Parameswaran N., Hall C.S., McCabe L.R., and Spielman W.S. Adrenomedullin increases AP-1 expression in rat mesangial cells via activation of protein kinase-A and p38 MAPK. Cell Physiol. Biochem. 13 (2003) 367-374
36. Pesce C.G., Nogues G., Alonso C.R., Baralle F.E., and Kornblihtt A.R. Interaction between the (-170) CRE and the (-150) CCAAT box is necessary for efficient activation of the fibronectin gene promoter by cAMP and ATF-2. FEBS Lett. 457 (1999) 445-451
37. Qin Y., Li X.W., Wen Y.B., et al. Effects of rosiglitazone on the expression connective tissue growth factor in tubulointerstitium in KKA(y) mice. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 28 (2006) 817-821
38. Quinn M., Angelico M.C., Warram J.H., and Krolewski A.S. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39 (1996) 940-945
39. Reddy M.A.A.S., Kim Y.S., Lanting L., Rossi J., Kang S.W., Nadler J.L., Shahed A., and Natarajan R. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Am. J. Physiol. Renal. Physiol. 283 (2002) F985-994
40. Schnaper H.W., Hayashida T., Hubchak S.C., and Poncelet A.C. TGF-beta signal transduction and mesangial cell fibrogenesis. Am. J. Physiol. Renal Physiol. 284 (2003) F243-252
41. Seger R., and Krebs E.G. The MAPK signaling cascade. FASEB J. 9 (1995) 726-735
42. Tan Y.R.J., Zhang A., Cariati S., Cohen P., and Comb M.J. FGF and stress regulate CREB and ATF-1 via a pathway involving p38MAP kinase and MAPKAP kinase-2. EMBO J. 15 (1996) 4629-4642
43. Tsuchida A., Yamauchi T., and Kadowaki T. Nuclear receptors as targets for drug development: molecular mechanisms for regulation of obesity and insulin resistance by peroxisome proliferator-activated receptor gamma, CREB-binding protein, and adiponectin. J. Pharmacol. Sci. 97 (2005) 164-170
44. Wang J., Huang H., Liu P., Tang F., Qin J., Huang W., Chen F., Guo F., Liu W., and Yang B. Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats. Eur. J. Pharmacol. 553 (2006) 297-303
45. Wang W., Liu F., and Chen N. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts. Mediators Inflamm. 2007 (2007) 62641
46. Wang Y., Huang S., Sah V.P., Ross Jr. J., Brown J.H., Han J., and Chien K.R. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 273 (1998) 2161-2168
47. Woo S.W., Nan J.X., Lee S.H., Park E.J., Zhao Y.Z., and Sohn D.H. Aloe emodin suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Pharmacol. Toxicol. 90 (2002) 193-198
48. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
49. Yasuda E., Tokuda H., Ishisaki A., Hirade K., Kanno Y., Hanai Y., Nakamura N., Noda T., Katagiri Y., and Kozawa O. PPAR-gamma ligands up-regulate basic fibroblast growth factor-induced VEGF release through amplifying SAPK/JNK activation in osteoblasts. Biochem. Biophys. Res. Commun. 328 (2005) 137-143
50. Yin T., Sandhu G., Wolfgang C.D., Burrier A., Webb R.L., Rigel D.F., Hai T., and Whelan J. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J. Biol. Chem. 272 (1997) 19943-19950
51. Yung S., Liu Z.H., Lai K.N., Li L.S., and Chan T.M. Emodin ameliorates glucose-induced morphologic abnormalities and synthesis of transforming growth factor beta1 and fibronectin by human peritoneal mesothelial cells. Perit. Dial. Int. 21 Suppl. 3 (2001) S41-47